Skip to main content
Amphastar Pharmaceuticals, Inc. logo

Amphastar Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · AMPH ISIN · US03209R1032 LEI · 54930055TH0ZLSAQMJ38 US Manufacturing
Filings indexed 916 across all filing types
Latest filing 2018-07-11 Director's Dealing
Country US United States of America
Listing US AMPH

About Amphastar Pharmaceuticals, Inc.

https://amphastar.com/

Amphastar Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing, manufacturing, and marketing technically challenging medications. Its portfolio includes generic and proprietary injectable, intranasal, and inhalation products. The company specializes in complex medications such as biologics derived from living cells, proteins, and interchangeable biosimilars. Amphastar also develops innovative drug delivery systems and proprietary technological platforms for various routes of administration.

Recent filings

Filing Released Lang Actions
4
Director's Dealing
2018-07-11 English
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content describes a private placement of equity by a subsidiary, including details about the transaction and the parties involved. It also references a press release about the expansion plans and closing of the private placement. There are no financial statements or detailed financial data included, only a description of the financing event and related agreements. This fits the category of a Capital/Financing Update, as it provides information on company fundraising and capital structure changes. The document length is 5239 characters, sufficient to contain substantive information about the financing event rather than just an announcement of a report. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2018-07-09 English
4
Director's Dealing
2018-07-03 English
4
Director's Dealing
2018-06-18 English
4
Director's Dealing
2018-06-18 English
3
Director's Dealing
2018-06-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.